Renalytix AI, a company developing of artificial intelligence-enabled clinical diagnostics for kidney disease, announced that it has been granted
You may be a little overwhelmed by all the new diabetes management apps out there. Well, you’re not alone. Now, a new study from Singapore
LifeScan Inc., a leader in blood glucose monitoring, recently announced the new OneTouch Verio Reflect™ system received Health Canada’s
Companion Medical announced last week it’s expanding access to its InPen™ System which will now be available in retail pharmacies
LifeScan, Inc. recently introduced the OneTouch Reveal® Plus mobile app, which has received a Health Canada license. It will soon be available to
Diabetes is a global pandemic. One in 11 adults has diabetes and in 2040, 1 in 10 adults will have diabetes. It is one of the most important global
Type 2 diabetes is among the strongest risk factors for heart disease, yet up to 1 in 3 people living with diabetes don’t know they have it and
Glooko, a company focused on diabetes management says its mobile app available for both Android and iOS, will now be available for free for any
Senseonics Holdings, Inc. announced the integration of Eversense CGM data into the Glooko diabetes data management platform. Senseonics is focused on
Abbott and Novo Nordisk today announced a deal that connects two key technologies: Continuous glucose monitoring (CGM) and connected insulin pens.
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: